Join the conversation

Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

Trending Tickers

MRK logo
Top trending tickerMRK
$133.72
0.69%
#1
Merck is drawing attention as traders speculate it could acquire SELLAS after SELLAS reported positive Phase 3 REGAL results and Merck discontinued its BELLWAVE blood-cancer program. The timing has fueled buyout rumors, but no talks are confirmed, and some traders dismiss the speculation as unfounded.
JNJ logo
JNJ
$270.47
1.25%
#2
Speculation that J&J could acquire Sellas Life Sciences ($SLS), amid discussion of Sellass REGAL trial results, is driving much of the conversation. Some traders see J&J as a likely oncology suitor, while others dismiss the buyout chatter as unfounded; no deal is confirmed.
ABBV logo
ABBV
$286.20
0.94%
#3
Traders frequently speculate that AbbVie could acquire Sellas Life Sciences, arguing that Sellass cancer drug candidates could complement AbbVies AML business; no deal is confirmed. Other discussion highlights AbbVies earnings performance and growth from Skyrizi and Rinvoq, alongside profit-taking and share-price volatility.
UCO logo
UCO
$48.84
0.14%
#4
Crude-oil volatility driven by Middle East tensions and uncertainty over Iran diplomacy is the main focus, with traders weighing potential supply disruptions against peace prospects and oversupply concerns. As a 2x daily crude-oil fund, UCO is drawing both bullish hedging interest and caution about sharp swings.
UUP logo
UUP
$29.64
0.03%
#5
Traders are focused on the U.S. dollars broad strength, which they associate with higher U.S. yields and expectations of a hawkish Fed amid persistent inflation concerns. Dollar bulls see momentum continuing, while others argue the strength may fade; many also discuss its pressure on gold, commodities and risk assets.
NIGHT logo
NIGHT
$0.0484
6.66%
#6
Midnights privacy-network rollout and adoption prospects, including its live mainnet and Monument Banks planned tokenized deposits, are drawing attention, but traders say the developments have yet to translate into sustained price strength. Bullish holders emphasize institutional and cross-chain privacy use cases, while skeptics point to weak demand, token selling and lingering concern about the Wanchain bridge exploit.
MSTY logo
MSTY
$7.61
9.73%
#7
MSTY is under pressure alongside Bitcoin and its underlying MSTR exposure, with traders pointing to crypto weakness and MSTRs steep losses as the backdrop. The discussion is dominated by concern over price and NAV erosion, falling distributions, and possible reverse splits, while some holders are buying the dip and counting on a Bitcoin recovery and continued income.
CLX logo
CLX
$104.73
0.16%
#8
Clorox is drawing attention after traders highlighted a quarterly earnings and revenue beat and its maintained fiscal-year outlook, though some remain cautious about margin pressure and consumer demand. The stocks recent breakout and call activity have also fueled unconfirmed takeover speculation.
LNG logo
LNG
$294.84
0.18%
#9
Chenieres strong Q3 results, raised full-year guidance and dividend increase are driving attention, alongside discussion of expanded export capacity and robust global LNG demand. Traders are broadly positive but debate whether the gains are already priced in, often comparing Chenieres established, contracted business with Venture Globals growth prospects.
SCO logo
SCO
$20.54
0.44%
#10
SCO is drawing attention as traders use the leveraged inverse crude ETF to bet on oil falling amid shifting Iran/Hormuz risk, peace-talk speculation, and expectations of recovering supply or oversupply. Views remain split over renewed supply-disruption risks, while many holders complain that daily resets and futures-curve decay have kept SCO from matching oils moves over longer periods.

Latest Market News

About Stocktwits

With over 10 million users, Stocktwits helps you tap into the real-time sentiment and trending insights across stocks, ETFs, and crypto.